Skip to main content
. 2021 Mar 10;13(6):8481–8496. doi: 10.18632/aging.202659

Table 1. Enriched GO terms in the PCLMN.

GO term P-value Associated genes (%)
regulation of receptor binding 2.67E-05 10.71
T cell selection 1.64E-04 5.88
positive T cell selection 6.78E-05 7.89
T cell differentiation in thymus 2.20E-05 5.06
granulocyte chemotaxis 4.15E-07 4.32
neutrophil migration 2.80E-07 4.62
neutrophil chemotaxis 1.09E-07 5.41
interleukin-12 production 3.23E-04 4.69
regulation of interleukin-12 production 2.94E-04 4.84
somatic diversification of immune receptors 4.75E-04 4.11
somatic cell DNA recombination 4.75E-04 4.11
chemokine production 4.93E-05 4.12
regulation of cytokine production involved in immune response 5.56E-05 4.00
regulation of chemokine production 4.01E-05 4.35
regulation of leukocyte apoptotic process 4.01E-05 4.35
regulation of lymphocyte apoptotic process 2.67E-04 5.00
heterotypic cell-cell adhesion 3.38E-04 4.62
chemokine production 4.93E-05 4.12
regulation of lipid catabolic process 3.38E-04 4.62
leukocyte aggregation 3.03E-06 21.43
regulation of reactive oxygen species biosynthetic process 5.56E-05 4.00
negative regulation of reactive oxygen species metabolic process 3.53E-04 4.55
regulation of cytokine production involved in immune response 5.56E-05 4.00
regulation of chemokine production 4.01E-05 4.35
regulation of heterotypic cell-cell adhesion 2.39E-05 11.11
negative regulation of reactive oxygen species biosynthetic process 4.42E-05 9.09
positive regulation of cytokine production involved in immune response 3.69E-04 4.48
positive regulation of chemokine production 4.03E-04 4.35
positive regulation of heterotypic cell-cell adhesion 4.65E-06 18.75
unsaturated fatty acid biosynthetic process 3.38E-04 4.62
regulation of lymphocyte apoptotic process 2.67E-04 5.00